Bodhi Tree net loss narrows to $105,338 in FY26 nine months ended June 30; revenue rises to $25,000

BDTB•2026-08-14

Nine-month loss and revenue update

Bodhi Tree Biotechnology posted a net loss of USD 23,194 for the three months ended June 30, 2026, widening from USD 20,774.

Revenue was USD 10,000, swinging from no revenue a year earlier, while general and administrative expenses climbed to USD 33,195 from USD 19,975.

For the nine months ended June 30, net loss narrowed to USD 105,338 from USD 138,979 as revenue rose to USD 25,000 from USD 5,000.

Operating cash outflow totaled USD 105,418 for the nine months, versus USD 140,054, with no investing or financing activity reported.

Management said it plans to fund operations via public offerings, private placements, or stock-for-services until profitable operations are achieved.

Sources

Bodhi Tree net loss narrows to $105,338 in FY26 nine months ended June 30; revenue rises to $25,000

Sec

Bodhi Tree net loss narrows to $105,338 in FY26 nine months ended June 30; revenue rises to $25,000

Nine-month loss and revenue update

Related News

GP-Act III Acquisition net income drops 90.28% to $290,121 in Q2 FY26

Real and RE/MAX Holdings Securityholders Approve Proposed Combination

Reserve Petroleum Q2 FY26 net income more than doubles to $2.55 million; revenue rises 54% to $5.35 million

Sources

Bodhi Tree net loss narrows to $105,338 in FY26 nine months ended June 30; revenue rises to $25,000

Joby director Paul Sciarra disposes of 62,500 common shares worth $497,500

BiomX delays Q2 10-Q filing, cites accounting staff absence and acquisition accounting review